Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo

RationaleThe development of inhibitors of microsomal prostaglandin (PG)E2 synthase-1 (mPGES-1) was driven by the promise of attaining antiinflammatory agents with a safe cardiovascular profile because of the possible diversion of the accumulated substrate, PGH2, towards prostacyclin (PGI2).Objective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Luigia Di Francesco, Annalisa Bruno, Emanuela Ricciotti, Stefania Tacconelli, Melania Dovizio, Paloma Guillem-Llobat, Maria Alessandra Alisi, Beatrice Garrone, Isabella Coletta, Giorgina Mangano, Claudio Milanese, Garret A. FitzGerald, Paola Patrignani
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020-04-01
Colecção:Frontiers in Pharmacology
Assuntos:
microsomal prostaglandin E2 synthase-1 inhibitors
microsomal prostaglandin E2 synthase-1
cyclooxygenases-2
whole blood
prostaglandin E2
TXB2
Acesso em linha:https://www.frontiersin.org/article/10.3389/fphar.2020.00374/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados